Published in Curr Med Res Opin on August 01, 2010
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males. Cardiovasc Diabetol (2010) 1.35
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis (2012) 1.01
Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants. Atherosclerosis (2010) 0.88
Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians. Ther Adv Chronic Dis (2011) 0.85
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol (2016) 0.84
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. Diabetes Metab Syndr Obes (2013) 0.79
Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids. Cardiovasc Diabetol (2014) 0.79
Lipid-related residual risk and renal function for occurrence and prognosis among patients with first-event acute coronary syndrome and normal LDL cholesterol. Lipids Health Dis (2011) 0.76
[Clinical importance of HDL cholesterol]. Herz (2016) 0.76
Additional Treatment with Fenofibrate for Patients Treated with Pitavastatin Under Ordinary Medical Practice for Hypertriglyceridemia in Japan (APPROACH-J Study). Jpn Clin Med (2011) 0.75
Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants. Transl Res (2011) 0.75
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13
Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68
Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med (1996) 2.03
Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab (1997) 1.88
Cardiovascular disease in women. Circulation (1993) 1.87
Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78
Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet (1999) 1.76
Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75
A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58
Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50
Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care (2000) 1.46
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40
Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40
Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol (1995) 1.39
The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39
Detection of low-range diabetic microalbuminuria: Micral-Test revisited. Diabet Med (1994) 1.38
Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb (1993) 1.38
Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med (1993) 1.38
Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) (2003) 1.27
Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension (1999) 1.14
Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet (1984) 1.12
Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.11
Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res (2001) 1.11
A prospective study of nutritional factors and hypertension among US women. Circulation (1989) 1.08
The association of dietary fat with serum cholesterol in vegetarians: the effect of dietary assessment on the correlation coefficient. Am J Epidemiol (1988) 1.03
Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens (2001) 1.00
Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx. Endocrinology (1988) 1.00
Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol (1990) 0.99
Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res (1994) 0.97
Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res (1999) 0.96
Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J (2001) 0.96
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol (1999) 0.96
Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost (1992) 0.96
Lipid-lowering therapy in acute coronary syndromes. JAMA (2001) 0.94
Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse islets. Biochem J (1988) 0.94
Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. Am J Cardiol (1990) 0.92
A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol (1995) 0.91
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90
Modulation of the effect of acetylcholine on insulin release by the membrane potential of B cells. Endocrinology (1987) 0.90
More on chewing the fat. The good fat and the good cholesterol. N Engl J Med (1991) 0.90
Age and living in an urban environment are major determinants of diabetes among South Kivu Congolese adults. Diabetes Metab (2012) 0.89
Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects. Diabetes Metab (2003) 0.89
Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy. Ann Endocrinol (Paris) (2011) 0.89
Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA (1981) 0.89
Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol (2001) 0.89
Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol (1992) 0.89
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol (1995) 0.89
Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr (1987) 0.88
Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med (1986) 0.88
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol (2001) 0.87
Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension (1984) 0.87
Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest (1993) 0.86
Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. JAMA (1985) 0.86
Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetes. Diabet Med (2005) 0.83
Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man. J Clin Pharmacol (1988) 0.83
Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab (1998) 0.83
Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med (1986) 0.82
Predictive factors associated with primary failure to exenatide and non goal attainment in patients with type 2 diabetes. Acta Clin Belg (2013) 0.82
Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol (1999) 0.81
Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study. Int J Obes (Lond) (2011) 0.81
Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol (1987) 0.81
Effects of shrimp consumption on plasma lipoproteins. Am J Clin Nutr (1996) 0.81
Non-pharmacological management of type 2 diabetes. Acta Clin Belg (2004) 0.81
Diet type and changes in food cravings following weight loss: findings from the POUNDS LOST Trial. Eat Weight Disord (2012) 0.81
Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group. Am J Cardiol (1993) 0.80
Stability of blood pressure in vegetarians receiving dietary protein supplements. Hypertension (1984) 0.80
The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. Am J Clin Nutr (1993) 0.79
Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol (1989) 0.79
Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. Am J Cardiol (1990) 0.79
Reported rates, incentives, and effectiveness of major vaccinations in 501 attendees at two diabetes clinics. Diabetes Care (1997) 0.79
Erectile dysfunction and lower androgenicity in type 1 diabetic patients. Diabetes Metab (2001) 0.78
Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol. J Clin Endocrinol Metab (1999) 0.78
Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans. Arteriosclerosis (1987) 0.78
Is there a role for osmotic events in the exocytotic release of insulin? Endocrinology (1986) 0.78
Premature coronary deaths in Asians. BMJ (1996) 0.78
Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients. Diabetes Metab (2001) 0.78
Effects of inherent responsiveness to diet and day-to-day diet variation on plasma lipoprotein concentrations. Am J Clin Nutr (1996) 0.78